31. Karanth S. and McCann S. M. (1991) Anterior pituitary hormone control by interleukin 2. Proc. natn. Acad. Sci.
U.S.A. 88, 2961–2965.
32. Katsuura G., Gottschall P. E. and Arimura A. (1988) Identification of a high-aYnity receptor for interleukin-1 beta
in rat brain. Biochem. biophys. Res. Commun. 156, 61–67.
33. Kent S., Bluthe R.-M., Kelley K. W. and Dantzer R. (1992) Sickness behavior as a new target for drug development.
Trends pharmac. Sci. 13, 24–28.
34. Kokkinidis L. and McCarter L. (1990) Postcocaine depression and sensitization of brain stimulation reward: analysis
of reinforcement and performance eVects. Pharmac. Biochem. Behav. 36, 463–471.
35. Lacosta S., Merali Z. and Anisman H. (1995) Cytokine-induced endocrine, neurochemical and behavioral alterations.
Soc. Neurosci. Abstr. 21, 1397.
36. Lacosta S., Merali Z., Zalcman S. and Anisman H. (1994) Time-dependent in vivo mesolimibic dopamine variations
following antigenic challenge. Brain Res. 664, 225–230.
37. Lapchak P. A. (1992) A role for interleukin-2 in the regulation of striatal dopaminergic function. NeuroReport 3,
165–168.
38. Lapchak P. A., Araujo D. M., Quirion R. and Beaudet A. (1991) Immunoautoradiographic localization of interleukin
2-like immunoreactivity and interleukin-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience
44, 173–184.
39. Li A.-J., Katafuchi T., Oda S., Hori T. and Oomura Y. (1997) Interleukin-6 inhibits long-term potentiation in rat
hippocampal slices. Brain Res. 748, 30–38.
40. Linthorst A. C. E., Flachskamm C., Muller-Preuss P., Holsboer F. and Reul J. M. H. M. (1995) EVect of bacterial
endotoxin and interleukin-1â on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. J. Neurosci. 15, 2920–2934.
41. Lyson K. and McCann S. M. (1991) The eVect of interleukin-6 on pituitary hormone release in vivo and in vitro.
Neuroendocrinology 54, 262–266.
42. Lyson K. and McCann S. M. (1993) Alpha-melanocyte-stimulating hormone abolishes IL-1 and IL-6-induced
corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58, 191–195.
43. Maes M. (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmac. 19, 11–38.
44. Maier S. F. and Watkins L. R. (1995) Intracerebroventricular interleukin-1 receptor antagonist blocks the
enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695,
279–282.
45. Maness L. M., Banks W. A., Zadina J. E. and Kastin A. J. (1995) Selective transport of blood-borne interleukin-1
alpha into the posterior division of the septum of the mouse brain. Brain Res. 70, 83–88.
46. Masana M. I., Heyes M. P. and MeVord I. N. (1990) Indomethacin prevents increased catecholamine turnover in rat
brain following systemic endotoxin challenge. Prog. Neuropsychopharmac. 14, 609–621.
47. McClain C., Cohen D., Phillips R., Ott L. and Young B. (1991) Increased plasma and ventricular fluid interleukin-6
levels in patients with head injury. J. Lab. clin. Med. 118, 225–231.
48. Merali Z., Lacosta S. and Anisman H. (1997) EVects of interleukin-1â and mild stress on alterations
of norephinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study. Brain Res. 761,
225–235.
49. Merrill J. E. (1990) Interleukin-2 eVects in the central nervous system. Ann. N. Y. Acad. Sci. 594, 188–199.
50. Mohankumar P. S., Thyagarajan S. and Quadri S. K. (1991) Interleukin-1 stimulates the release of dopamine and
dihydroxyphenylacetic acid from hypothalamus in vivo. Life Sci. 48, 925–930.
51. Mohankumar P. S., Thyagarajan S. and Quadri S. K. (1993) Interleukin-1â increases 5-hydroxyindoleacetic acid
release in the hypothalamus in vivo. Brain Res. Bull. 31, 745–748.
52. Muramami N., Fukata J., Tsukada T., Kobayashi H., Ebisui O., Segawa H., Muro S., Imura H. and Nakao K. (1993)
Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus,
pituitary, adrenal gland, and spleen. Endocrinology 133, 2574–2578.
53. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K. and Imura H. (1988) Interleukin-6 stimulates the
secretion of adrenocorticotrophic hormone in conscious, freely moving rats. Biochem. biophys. Res. Commun. 155,
1459–1461.
54. Nistico G. (1993) Communications among central nervous system, endocrine and immune systems: interleukin-2.
Prog. Neurobiol. 40, 463–475.
55. Nistico G. and De Sarro G. (1991) Is interleukin-2 a neuromodulator in the brain? Trends Neurosci. 14, 146–150.
56. Paulson P. E. and Robinson T. E. (1995) Amphetamine-induced time-dependent sensitization of dopamine
neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19, 56–65.
57. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
58. Petitto J. M., McCarthy D. B., Rinker C. M., Huang Z. and Getty T. (1997) Modulation of behavioral and
neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73,
183–190.
59. Plata-Salaman C. R. (1991) Immunoregulators in the nervous system. Neurosci. biobehav. Rev. 15, 185–215.
60. Puglisi-Allegra S., Imperato A., Angelucci L. and Cabib S. (1991) Acute stress induces time-dependent responses in
dopamine mesolimbic system. Brain Res. 554, 217–222.
61. Quan N., Sundar S. K. and Weiss J. M. (1994) Induction of interleukin-1 in various brain regions after peripheral and
central injections of lipopolysaccharide. J. Neuroimmunol. 49, 125–134.
62. Ringheim G. E., Burgher K. L. and Heroux J. A. (1995) Interleukin-6 mRNA expression by cortical neurons in
culture: evidence for neuronal sources of IL-6 production in the brain. J. Neuroimmunol. 63, 113–123.
63. Rivest S. (1995) Molecular mechanisms and neural pathways mediating the influence of interleukin-1 on the activity
of neuroendocrine CRF motoneurons in the rat. Int. J. dev. Neurosci. 13, 135–146.
64. Rivier C. (1990) Role of endotoxin and interleukin-1 in modulating ACTH, LH and sex steroid secretion. In
Circulating Regulatory Factors and Neuroendocrine Function (eds Porter J. C. and Jezova D.), pp. 295–302. Plenum,
New York.
